59
Participants
Start Date
September 6, 2017
Primary Completion Date
May 5, 2020
Study Completion Date
September 24, 2029
Brentuximab vedotin
Brentuximab vedotin infusion
Doxorubicin
Doxorubicin infusion
Vinblastine
Vinblastine infusion
Dacarbazine
Dacarbazine infusion
Ospedale Pediatrico Bambino Gesu,UOC Onco-ematologia, Roma
Azienda Ospedaliera Citta della Salute e della Scienza di Torino, Torino
Fondazione IRCCS Policlinico San Matteo, Pavia
Cincinnati Children's Hospital Medical Center, Cincinnati
Azienda Ospedaliero Universitaria Ospedale Pediatrico Meyer, Florence
Children's Hospital Colorado, Aurora
Hospital Sao Rafael S/A, Salvador
Jardim das Americas, Paranã
INCA - Instituto Nacional de Cancer, Rio de Janeiro
GRAACC - Grupo de Apoio ao Adolescente e a Crianca com Cancer, São Paulo
ICr - Instituto da Crianca - HCFMUSP, São Paulo
Hospital Santa Marcelina, São Paulo
NHO Nagoya Medical Center, Nagoya
St. Marianna University School of Medicine Hospital, Kawasaki-shi
Lead Sponsor
Takeda
INDUSTRY